Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
Urologic Oncology: Seminars and Original Investigations, 06/01/2012Banek S et al.
Fluorescence–in–situ–hybridization showed a performance in detecting bladder cancer comparable to cytology but a larger number or false–positive results. It remains to be investigated if chromosomal instability can be detected earlier than morphologic changes of exfoliated bladder cancer cells.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.